Startseite ATP synthase deficiency due to m.8528T>C mutation – a novel cause of severe neonatal hyperammonemia requiring hemodialysis
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

ATP synthase deficiency due to m.8528T>C mutation – a novel cause of severe neonatal hyperammonemia requiring hemodialysis

  • Tamara Žigman ORCID logo , Katarina Šikić , Danijela Petković Ramadža , Johannes Mayr , Saskia Wortmann , Holger Prokisch , Dorotea Ninković , Daniel Dilber , Dalibor Šarić , Filip Rubić , Slobodan Galić , Jasna Slaviček , Dražen Belina , Ksenija Fumić und Ivo Barić EMAIL logo
Veröffentlicht/Copyright: 13. November 2020
Journal of Pediatric Endocrinology and Metabolism
Aus der Zeitschrift Journal of Pediatric Endocrinology and Metabolism Band 34 Heft 3

Abstract

Objectives

Hyperammonemia in a newborn is a serious condition, which requires prompt intervention as it can lead to severe neurological impairment and death if left untreated. The most common causes of hyperammonemia in a newborn are acute liver failure and inherited metabolic disorders. Several mitochondrial disorders have been described as a cause of severe neonatal hyperammonemia.

Case presentation

Here we describe a new case of adenosine-triphosphate (ATP) synthase deficiency due to m.8528T>C mutation as a novel cause of severe neonatal hyperammonemia. So far six patients with this mutation have been described but none of them was reported to need hemodialysis in the first days of life.

Conclusion

This broadens the so far known differential diagnosis of severe neonatal hyperammonemia requiring hemodialysis.

Keywords: ATP synthase deficiency; hemodialysis; hyperammonemia
Corresponding author: Ivo Barić, MD, PhD, Full Professor of Pediatrics, Division for Genetics and Metabolic Diseases, Department of Pediatrics, University Hospital Center Zagreb, Kišpatićeva 12, 10000Zagreb, Croatia; and School of Medicine, University of Zagreb, Zagreb, Croatia, Phone: +385 1 2388 121, +385 1 2388 318, Fax: +385 1 2367 442, E-mail:
Tamara Žigman and Katarina Šikić have equally contributed to this article.

Funding source: German Federal Ministry of Education and Research

Award Identifier / Grant number: 01GM1603

  1. Research funding: H. P. was supported by a German Federal Ministry of Education and Research (BMBF and Horizon2020) through the E-Rare project GENOMIT (01GM1603).

  2. Author contributions: All authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. T. Ž. and K. Š. wrote the manuscript and did literature search. I. B. formulated the idea of the manuscript. K. F. took part in laboratory diagnostics. J. M., S. M., and H. P. performed genetic analysis. T. Ž., D. P. R., D. N., D. D., D. Š., F. R., J. S., D. B., and I. B. were involved in patient management. All authors provided critical feedback and approved the final manuscript.

  3. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration.

References

1. Imai-Okazaki, A, Kishita, Y, Kohda, M, Mizuno, Y, Fushimi, T, Matsunaga, A, et al.. Cardiomyopathy in children with mitochondrial disease: prognosis and genetic background. Int J Cardiol 2019;279:115–21. https://doi.org/10.1016/j.ijcard.2019.01.017.Suche in Google Scholar PubMed

2. Miyake, N, Yano, S, Sakai, C, Hatakeyama, H, Matsushima, Y, Shiina, M, et al.. Mitochondrial complex III deficiency caused by a homozygous UQCRC2 mutation presenting with neonatal-onset recurrent metabolic decompensation. Hum Mutat 2013;34:446–52. https://doi.org/10.1002/humu.22257.Suche in Google Scholar PubMed

3. Jonckheere, AI, Hogeveen, M, Nijtmans, LGJ, Van Den Brand, MAM, Janssen, AJM, Diepstra, JHS, et al.. A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy. J Med Genet 2008;45:129–33. https://doi.org/10.1136/jmg.2007.052084.Suche in Google Scholar PubMed

4. Kytövuori, L, Lipponen, J, Rusanen, H, Komulainen, T, Martikainen, MH, Majamaa, K. A novel mutation m.8561C>G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism. J Neurol 2016;263:2188–95. https://doi.org/10.1007/s00415-016-8249-2.Suche in Google Scholar PubMed

5. Ware, SM, El-Hassan, N, Kahler, SG, Zhang, Q, Ma, YW, Miller, E, et al.. Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes. J Med Genet 2009;46:308–14. https://doi.org/10.1136/jmg.2008.063149.Suche in Google Scholar PubMed

6. Imai, A, Fujita, S, Kishita, Y, Kohda, M, Tokuzawa, Y, Hirata, T, et al.. Rapidly progressive infantile cardiomyopathy with mitochondrial respiratory chain complex V deficiency due to loss of ATPase 6 and 8 protein. Int J Cardiol 2016;207:203–5. https://doi.org/10.1016/j.ijcard.2016.01.026.Suche in Google Scholar PubMed

7. Dautant, A, Meier, T, Hahn, A, Tribouillard-Tanvier, D, di Rago, JP, Kucharczyk, R. ATP synthase diseases of mitochondrial genetic origin. Front Physiol 2018;9:1–16. https://doi.org/10.3389/fphys.2018.00329.Suche in Google Scholar PubMed PubMed Central

8. Häberle, J. Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. Arch Biochem Biophys 2013;536:101–8. https://doi.org/10.1016/j.abb.2013.04.009.Suche in Google Scholar PubMed

9. Taylor, RW, Pyle, A, Griffin, H, Blakely, EL, Duff, J, He, L, et al.. Use of whole exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiency. J Am Med Assoc 2019;312:68–77. https://doi.org/10.1001/jama.2014.7184.Suche in Google Scholar PubMed PubMed Central

Received: 2020-07-02
Accepted: 2020-10-05
Published Online: 2020-11-13
Published in Print: 2021-03-26

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. Inborn errors of immunity and metabolic disorders: current understanding, diagnosis, and treatment approaches
  4. Original Articles
  5. Evaluation of hydration status of children with obesity—a pilot study
  6. Relationship between insulin-like growth factor-1, insulin resistance and metabolic profile with pre-obesity and obesity in children
  7. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus
  8. Karyotype is associated with timing of ovarian failure in women with Turner syndrome
  9. The role of makorin ring finger protein-3, kisspeptin, and neurokinin B in the physiology of minipuberty
  10. Brain MRIs may be of low value in most children diagnosed with isolated growth hormone deficiency
  11. Significant improvement in bone mineral density in pediatric celiac disease: even at six months with gluten-free diet
  12. Population-based waist circumference reference values in Japanese children (0–6 years): comparisons with Dutch, Swedish and Turkish preschool children
  13. Extended growth charts for Indian children
  14. Rib fractures in infancy, case-series and register case-control study from Sweden
  15. Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life
  16. Case Reports
  17. Transient benign hyperphosphatasemia due to COVID-19: the first case report
  18. ATP synthase deficiency due to m.8528T>C mutation – a novel cause of severe neonatal hyperammonemia requiring hemodialysis
  19. IgG4-related hypophysitis in adolescence
  20. Graves’ disease in a five-month-old boy with an unusual treatment course
  21. Oral sodium phenylbutyrate for hyperammonemia associated with congenital portosystemic shunt: a case report
  22. Severe multisystem organ dysfunction in an adolescent with simultaneous presentation of Addison’s and Graves’ disease
https://doi.org/10.1515/jpem-2020-0396
Schlagwörter für diesen Artikel
ATP synthase deficiency; hemodialysis; hyperammonemia

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. Inborn errors of immunity and metabolic disorders: current understanding, diagnosis, and treatment approaches
  4. Original Articles
  5. Evaluation of hydration status of children with obesity—a pilot study
  6. Relationship between insulin-like growth factor-1, insulin resistance and metabolic profile with pre-obesity and obesity in children
  7. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus
  8. Karyotype is associated with timing of ovarian failure in women with Turner syndrome
  9. The role of makorin ring finger protein-3, kisspeptin, and neurokinin B in the physiology of minipuberty
  10. Brain MRIs may be of low value in most children diagnosed with isolated growth hormone deficiency
  11. Significant improvement in bone mineral density in pediatric celiac disease: even at six months with gluten-free diet
  12. Population-based waist circumference reference values in Japanese children (0–6 years): comparisons with Dutch, Swedish and Turkish preschool children
  13. Extended growth charts for Indian children
  14. Rib fractures in infancy, case-series and register case-control study from Sweden
  15. Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life
  16. Case Reports
  17. Transient benign hyperphosphatasemia due to COVID-19: the first case report
  18. ATP synthase deficiency due to m.8528T>C mutation – a novel cause of severe neonatal hyperammonemia requiring hemodialysis
  19. IgG4-related hypophysitis in adolescence
  20. Graves’ disease in a five-month-old boy with an unusual treatment course
  21. Oral sodium phenylbutyrate for hyperammonemia associated with congenital portosystemic shunt: a case report
  22. Severe multisystem organ dysfunction in an adolescent with simultaneous presentation of Addison’s and Graves’ disease
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 26.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0396/html
Button zum nach oben scrollen